Skip to main content

Peer Review reports

From: Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience

Original Submission
23 Feb 2022 Submitted Original manuscript
25 Feb 2022 Reviewed Reviewer Report
16 Mar 2022 Reviewed Reviewer Report - Linda Al-hassany
19 Mar 2022 Author responded Author comments - Bianca Raffaelli
Resubmission - Version 2
19 Mar 2022 Submitted Manuscript version 2
Publishing
21 Mar 2022 Editorially accepted
30 Mar 2022 Article published 10.1186/s10194-022-01417-9

You can find further information about peer review here.

Back to article page